Angiodynamics (ANGO) Other Accumulated Expenses (2012 - 2026)

Angiodynamics has reported Other Accumulated Expenses for 13 years, with the latest figure at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 19.09% year-over-year to $4.7 million; the trailing twelve-month figure through Feb 2026 stood at $4.7 million (down 19.09% YoY), and the FY2025 full-year result was $7.4 million, down 2.51% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $4.7 million, down from $6.7 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $10.3 million in Q1 2024, with the low at $1.8 million in Q4 2023.
• Historically, Other Accumulated Expenses has averaged $5.0 million across 5 years, with a median of $4.7 million in 2026.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 408.79% — and 2025, when it plunged 43.88%.
• Angiodynamics' Other Accumulated Expenses stood at $2.6 million in 2022, then tumbled by 31.83% to $1.8 million in 2023, then surged by 408.79% to $9.0 million in 2024, then fell by 25.08% to $6.7 million in 2025, then sank by 30.68% to $4.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $4.7 million (Q1 2026), $6.7 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.